IP Library Granted Patent US 12,688,919
Granted Patent B2
US 12,688,919 · App. 17/578,761 · Granted Jul 21, 2026

Systems and methods for authenticating medical infusion lines

Inventors: Hans Utz (Decatur, GA); Dragan Nebrigic (Austin, TX)
Assignee: CHS Healthcare Ventures, Inc
G16H20/17A61M5/14A61M5/1582A61M5/162A61M5/172F21V33/0068G02B6/4442G02B6/4482G16H40/63H05B45/10H05B47/11A61L2103/15A61L2202/14A61M2005/1401A61M2005/14553A61M2205/14A61M2205/3306A61M2205/3313A61M2205/3317A61M2205/3633A61M2205/587A61M2205/6054A61M2205/6081A61M2205/8206A61M2207/00F21V2200/10
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,688,919
App. No.
17/578,761
Filed
Jan 19, 2022
Granted
Jul 21, 2026
Kind
B2
Art Unit
2877
USPC
356/300
Abstract

Aspects of systems and methods for authenticating illuminating medical infusion lines are disclosed. In one aspect a method for authenticating medical infusion lines utilizing a cap color detection assembly is disclosed. The method includes provisioning an electronic illuminator for illuminating medical infusion lines with a cap color detection assembly. Next, connecting a side scattering fiber optic cable with a fiber funnel cap that is configured with a visible color with the electronic illuminator. Then, transmitting a white light from the cap color detection assembly and recording reflected light from the fiber funnel cap. Then, converting the recorded reflective light to a color code. In another aspect a method for authenticating medical infusion lines is disclosed utilizing a fiber detection assembly. The method includes provisioning an electronic illuminator for illuminating medical infusion lines with a fiber detection assembly. Then connecting a side scattering fiber optic cable with a fiber funnel cap that is configured with a metallic plate with the electronic illuminator. Next, detecting a change in voltage as the fiber funnel cap of the side scattering fiber optic cable is connected, wherein a final voltage results in a magnetic flux key. Lastly, authenticating, by the MCU on the electronic illuminator, the magnetic flux key with stored parameters.

Claims (10)

1 . A method for authenticating medical infusion lines, comprising:

connecting a side scattering fiber optic cable with a fiber funnel cap having a visible color with an electronic illuminator that illuminates one or more medical infusion lines;

transmitting a white light from a cap color detection assembly of the electronic illuminator, and recording reflected light from the fiber funnel cap;

converting the reflected light to a color code; and

verifying by a microcontroller (MCU) onboard the electronic illuminator that the color code is an approved color code.

2 . The method of claim 1 , wherein a multiple band code is on the fiber funnel cap of the side scattering fiber optic cable.

3 . The method of claim 2 , further comprising transmitting the white light from the cap color detection assembly and recording reflected light from each band of the multiple band code.

4 . The method of claim 3 , further comprising converting the multiple band code to a color code.

5 . The method of claim 4 , further comprising verifying by the MCU on the electronic illuminator the multiple band color code is an approved color code.

6 . The method of claim 1 , further comprising alerting by the electronic illuminator that the side scattering fiber optic cable is authentic.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 17, 2022
From: NEBRIGIC, DRAGAN; UTZ, HANS
To: CHS HEALTHCARE VENTURES, INC
Reel/Frame 059038/0443 →
Continuity (2)
Provisional Application 63138961 · Jan 19, 2021
Related Publication 20220230725A1 · Jul 21, 2022
References Cited (33)
US 5041086A · Koenig et al. · 1991 [cited by applicant]
US 5423750A · Spiller · 1995 [cited by applicant]
US 5681285A · Ford et al. · 1997 [cited by applicant]
US 6059768A · Friedman · 2000 [cited by applicant]
US 7860583B2 · Condurso et al. · 2010 [cited by applicant]
US 8679075B2 · Lurvey et al. · 2014 [cited by applicant]
US 9501619B2 · Portnoy et al. · 2016 [cited by applicant]
US 10232107B2 · Utz · 2019 [cited by applicant]
US 20070106263A1 · Ward · 2007 [cited by applicant]
US 20100006171A1 · Tomlin et al. · 2010 [cited by applicant]
US 20110196306A1 · De La Huerga · 2011 [cited by applicant]
US 20110264463A1 · Kincaid et al. · 2011 [cited by applicant]
US 20130123579A1 · Adams et al. · 2013 [cited by applicant]
US 20140036276A1 · Gross · 2014 [cited by examiner]
US 20150018645A1 · Farkas · 2015 [cited by examiner]
US 20150190649A1 · Gelfand · 2015 [cited by examiner]
US 20160175521A1 · Adams et al. · 2016 [cited by applicant]
US 20170014023A1 · Kern · 2017 [cited by applicant]
US 20170021095A1 · Utz · 2017 [cited by applicant]
US 20170023216A1 · Utz · 2017 [cited by applicant]
US 20170258983A1 · Utz · 2017 [cited by applicant]
US 20170281855A1 · Utz · 2017 [cited by applicant]
US 20170340815A1 · Utz · 2017 [cited by applicant]
US 20180177938A1 · Provost et al. · 2018 [cited by applicant]
US 20190091398A1 · Utz · 2019 [cited by applicant]
US 20190168023A1 · Eltorai · 2019 [cited by examiner]
US 20200402228A1 · Talbert · 2020 [cited by examiner]
US 20220054738A1 · Pananen · 2022 [cited by examiner]
AU 2007282071A1 · 2008 [cited by applicant]
CN 102847204A · 2012 [cited by applicant]
EP 1157711A2 · 2008 [cited by applicant]
EP 2009533A1 · 2008 [cited by applicant]
WO 2019164988A1 · 2019 [cited by applicant]